Patent · US Expired

17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds

US6855836B2 · kind B2 · utility

0Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2001
Grant dateFeb 15, 2005
Priority date
Expiry dateDec 9, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J13/007
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to 17-methylene steroids, process for their production and pharmaceutical compositions that contain these compounds.The compounds according to the invention have a hybrid-type profile of action in the sense that they act as inhibitors of 5α-reductase and simultaneously as gestagens. They are therefore suitable for treating diseases that are the result of elevated androgen levels in certain organs and tissues in men and women. Together with other hormonal substances, such as an estrogen, testosterone or a strong androgen, the compounds according to the invention are suitable as contraceptive agents for women and for men.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.